We are live on
!
Find out more
PCM
Prelude Capital Management Portfolio holdings
AUM
$1.31B
1-Year Est. Return
62.02%
This Fund
S&P 500
This Quarter
Est. Return
+10.12%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.03B
AUM Growth
+$258M
(+15%)
Cap. Flow
+$193M
Cap. Flow
% of AUM
9.48%
Top 10 Holdings %
Top 10 Hldgs %
34.65%
Holding
2,402
New
679
Increased
420
Reduced
419
Closed
794
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$39.8M |
| 2 |
AGN
Allergan plc
AGN
|
+$27.2M |
| 3 |
BID
Sotheby's
BID
|
+$17.1M |
| 4 |
VSM
Versum Materials, Inc.
VSM
|
+$16.5M |
| 5 |
ARRY
Array Biopharma Inc
ARRY
|
+$15.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TVPT
Travelport Worldwide Limited
TVPT
|
+$27.8M |
| 2 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$19M |
| 3 |
Centene
CNC
|
+$15M |
| 4 |
LXFT
Luxoft Holding, Inc.
LXFT
|
+$14.7M |
| 5 |
NAVG
Navigators Group Inc
NAVG
|
+$10.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 7.64% |
| 2 | Technology | 6.61% |
| 3 | Industrials | 5.39% |
| 4 | Communication Services | 5.27% |
| 5 | Consumer Discretionary | 4.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBT
351
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $955K | 0.05% |
18,156
+7,708
| +74% | +$443K |
|
352
CVS Health
CVS
$122B
| $951K | 0.05% |
17,457
+5,557
| +47% | +$299K |
|
353
CALL
Amazon
AMZN
$3T
| $947K | 0.05% |
+10,000
| New | +$932K |
|
354
Honeywell
HON
$76.4B
| $945K | 0.05% |
5,743
+3,746
| +188% | +$596K |
|
|
ATVI
355
CALL
DELISTED
Activision Blizzard
ATVI
| $944K | 0.05% |
20,000
| – | – |
|
356
Boston Scientific
BSX
$71.6B
| $932K | 0.05% |
21,676
+2,042
| +10% | +$78.5K |
|
|
PTLA
357
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $931K | 0.05% |
34,328
+10,978
| +47% | +$344K |
|
358
PUT
Valero Energy
VLO
$84.1B
| $925K | 0.05% |
+10,800
| New | +$892K |
|
359
CALL
J.M. Smucker
SJM
$12.7B
| $922K | 0.05% |
8,000
| – | – |
|
360
Arlo Technologies
ARLO
$1.68B
| $917K | 0.05% |
+228,761
| New | +$898K |
|
361
Pacific Biosciences
PACB
$373M
| $917K | 0.05% |
+151,559
| New | +$1.06M |
|
|
AXDX
362
CALL
DELISTED
Accelerate Diagnostics
AXDX
| $915K | 0.05% |
4,000
+3,990
| +39,900% | +$780K |
|
363
PUT
McDonald's
MCD
$196B
| $914K | 0.05% |
4,400
-9,100
| -67% | -$1.8M |
|
|
EPZM
364
DELISTED
Epizyme, Inc
EPZM
| $912K | 0.04% |
72,700
+71,755
| +7,593% | +$923K |
|
|
RP
365
DELISTED
RealPage, Inc.
RP
| $904K | 0.04% |
+15,356
| New | +$930K |
|
366
Weibo
WB
$1.93B
| $901K | 0.04% |
+20,684
| New | +$1.16M |
|
|
HCCI
367
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $901K | 0.04% |
34,260
+2,551
| +8% | +$68.2K |
|
|
AMBR
368
DELISTED
Amber Road Inc
AMBR
| $899K | 0.04% |
+68,871
| New | +$773K |
|
369
Capri Holdings
CPRI
$1.7B
| $893K | 0.04% |
+25,742
| New | +$1.05M |
|
|
SAVE
370
PUT
DELISTED
Spirit Airlines, Inc.
SAVE
| $893K | 0.04% |
18,700
-2,900
| -13% | -$148K |
|
371
CALL
Apple
AAPL
$4.54T
| $891K | 0.04% |
18,000
-20,400
| -53% | -$994K |
|
372
iShares 20+ Year Treasury Bond ETF
TLT
$41.7B
| $891K | 0.04% |
6,710
+5,552
| +479% | +$705K |
|
373
Canadian Natural Resources
CNQ
$93.6B
| $890K | 0.04% |
67,386
-62,632
| -48% | -$860K |
|
374
CALL
Mohawk Industries
MHK
$9.22B
| $885K | 0.04% |
6,000
+4,700
| +362% | +$651K |
|
375
CALL
Akamai
AKAM
$17.1B
| $882K | 0.04% |
+11,000
| New | +$851K |
|
Similar funds
PFBT
CCP
SP
HCS
B
SPC
GPCM
MCM
Prelude Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Prelude Capital Management held 2,402 positions worth $2.03B, up 15% from $1.77B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Prelude Capital Management deployed $193M of net new capital in Q2 2019, opening 679 new positions and adding to 420 existing holdings. Its largest new stake was Anadarko Petroleum: 593,600 shares worth $41.9M.
By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 6.7% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Red Hat Inc, an estimated $8.6M trimmed.
- Prelude Capital Management's largest Q2 2019 buy was Anadarko Petroleum: 593,600 shares worth $41.9M.
- Prelude Capital Management added most to Allergan plc in Q2 2019, an estimated $27.2M increase.
- Prelude Capital Management's biggest Q2 2019 reduction was Red Hat Inc, cutting an estimated $8.6M.
- Prelude Capital Management fully exited Travelport Worldwide Limited in Q2 2019, selling an estimated $27.8M.
- Prelude Capital Management's ten largest holdings make up 35% of its $2.03B portfolio in Q2 2019.
- Prelude Capital Management opened 679 new positions and closed 794 in Q2 2019.
- Prelude Capital Management's portfolio value rose 15% quarter-over-quarter to $2.03B.
Based on Prelude Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.